Elizabeth focuses on the preparation and prosecution of patents in the pharmaceutical and biotechnology realm. She also prepares invalidity, freedom-to-operate, and patentability opinions. Elizabeth has technical expertise in a wide range of disciplines, including biomaterials, nanotechnology, CAR T therapy, and antibody discovery.
Jord BioScience Closes $7 Million Series B Financing
February 19, 2025
Cooley advised Jord BioScience on its $7 million Series B financing round, including the intellectual property due diligence in connection with the deal. The funding round will accelerate Jord BioScience’s development and commercialization of its microbial technologies to deliver next-generation crop inputs.
